Dolutegravir/Rilpivirine Combination Drug Market
This report contains market size and forecasts of Dolutegravir/Rilpivirine Combination Drug in gl ... Read More
This report contains market size and forecasts of Rilpivirine in global, including the following market information:
Global Rilpivirine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rilpivirine Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Rilpivirine companies in 2021 (%)
The global Rilpivirine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Self-production API Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rilpivirine include Janssen Cilag International, Gilead Sciences , ViiV Healthcare, Strides Pharma Science Limited, Pharmacare Limited and Aspen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rilpivirine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rilpivirine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Rilpivirine Market Segment Percentages, by Type, 2021 (%)
Self-production API
Outsourcing of API
Global Rilpivirine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Rilpivirine Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Drug Center
Other
Global Rilpivirine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Rilpivirine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rilpivirine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rilpivirine revenues share in global market, 2021 (%)
Key companies Rilpivirine sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Rilpivirine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Janssen Cilag International
Gilead Sciences
ViiV Healthcare
Strides Pharma Science Limited
Pharmacare Limited
Aspen
This report contains market size and forecasts of Dolutegravir/Rilpivirine Combination Drug in gl ... Read More
This report contains market size and forecasts of Ceritinib in global, including the following ma ... Read More
This report contains market size and forecasts of Lenvatini in global, including the following ma ... Read More
This report contains market size and forecasts of Anlotinib in Global, including the following ma ... Read More